Back to top

Nurix earns $10M milestone from Sanofi on STAT6 degrader Phase 1 start

Nurix Therapeutics (NRIX) announced that it has earned a $10M milestone payment following the initiation by its collaborator, Sanofi, of the Phase ...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Nurix Therapeutics, Inc. (NRIX)